Compound library

16 research compounds. Each page carries the dosing on record, the evidence split, reported effects and its graded pairings.

BPC-157

A pentadecapeptide studied mostly in animal models of tissue injury. Human evidence is small and uncontrolled, and no regulator ha

CJC-1295

A long-acting GHRH analogue studied for growth-hormone release. Two early human trials measured hormone levels; no human study her

Epithalon

A tetrapeptide studied for aging biology. Most evidence is animal or laboratory, with one older controlled clinical study in a ret

GHK-Cu

A naturally occurring copper peptide studied mostly for skin remodeling and wound healing. Its strongest human result is an older

Glutathione

A tripeptide antioxidant made in the body and studied in many small human trials. No approved therapeutic use appears here, and th

Ipamorelin

A selective growth-hormone secretagogue and ghrelin-receptor agonist. Outcome data are animal, and two completed human trials repo

MOTS-c

A mitochondrial-derived peptide studied mainly for metabolism in mice. Human data are observational only, and no completed human t

MT-2

A synthetic melanocortin receptor agonist studied for skin pigmentation. The human records here are case reports of harm after unr

PT-141

A melanocortin receptor agonist with one approved use and a disputed effect size. It has one pairing in this atlas from a study th

Retatrutide

A single peptide that activates the GIP, GLP-1 and glucagon receptors. It has the strongest human evidence in this atlas and, as o

Selank

A heptapeptide studied for anxiety. Two small randomized trials in anxiety disorders report improvement, and the rest of the evide

Semax

A heptapeptide studied for cognition and neuroprotection. The outcome evidence is mostly animal, and the human records are small i

SLU-PP-332

A synthetic exercise mimetic studied in mice for metabolism, heart failure and kidney aging. No human has been given it in this se

TB-500

A short fragment of thymosin beta-4. Almost all outcome data are animal or laboratory, and the one human randomized trial used the

Tesamorelin

A GHRH analogue and the one FDA-approved compound in this atlas, cleared for a specific HIV-related use. Evidence outside that use

Tirzepatide

An approved dual-incretin medicine with strong human evidence. This atlas covers it for research context only; its affiliate partn